Literature DB >> 26154784

Synthetic Cannabinoid-Related Illnesses and Deaths.

Jordan Trecki1, Roy R Gerona, Michael D Schwartz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26154784     DOI： 10.1056/NEJMp1505328

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  67 in total

1.  Abuse of New Psychoactive Substances: Threats and Solutions.

Authors:  Michael H Baumann; Nora D Volkow
Journal:  Neuropsychopharmacology       Date:  2015-08-25       Impact factor: 7.853

2.  Emerging and Underrecognized Complications of Illicit Drug Use.

Authors:  Alysse G Wurcel; Elisabeth A Merchant; Roger P Clark; David R Stone
Journal:  Clin Infect Dis       Date:  2015-08-12       Impact factor: 9.079

3.  In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors.

Authors:  Shivani Sachdev; Kiran Vemuri; Samuel D Banister; Mitchell Longworth; Michael Kassiou; Marina Santiago; Alexandros Makriyannis; Mark Connor
Journal:  Br J Pharmacol       Date:  2019-12-10       Impact factor: 8.739

4.  In Reply: "The importance of recognizing cannabinoid hyperemesis syndrome from synthetic marijuana use".

Authors:  Cecilia J Sorensen; Kristen DeSanto; Laura Borgelt; Kristina T Phillips; Andrew A Monte
Journal:  J Med Toxicol       Date:  2017-04-05

Review 5.  Synthetic Pot: Not Your Grandfather's Marijuana.

Authors:  Benjamin M Ford; Sherrica Tai; William E Fantegrossi; Paul L Prather
Journal:  Trends Pharmacol Sci       Date:  2017-02-02       Impact factor: 14.819

6.  More than bargained for: pneumomediastinum and subcutaneous emphysema associated with synthetic cannabinoid use.

Authors:  Richard Young; Andres Molina
Journal:  BMJ Case Rep       Date:  2018-12-22

7.  Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model.

Authors:  T W Grim; A J Morales; B F Thomas; J L Wiley; G W Endres; S S Negus; A H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2017-04-25       Impact factor: 4.030

8.  Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.

Authors:  Nicklaus Brandehoff; Axel Adams; Kyle McDaniel; Samuel D Banister; Roy Gerona; Andrew A Monte
Journal:  Clin Toxicol (Phila)       Date:  2017-09-01       Impact factor: 4.467

9.  Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Timothy W Lefever; Julie A Marusich; Richard C Kevin; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-03-16       Impact factor: 4.030

10.  In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.

Authors:  Thomas F Gamage; Daniel G Barrus; Richard C Kevin; David B Finlay; Timothy W Lefever; Purvi R Patel; Megan A Grabenauer; Michelle Glass; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  Pharmacol Biochem Behav       Date:  2020-04-02       Impact factor: 3.533
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.